@FiercePharma: Humira sales growth helped fuel Abbott's Q2 revenues. $2.3 billion. Good for spinoff if it continues. More | Follow @FiercePharma
> Mylan ($MYL) and Par Pharmaceuticals ($PRX) settled their patent fights with Somaxon Pharmaceuticals over Silenor, agreeing to launch dates in 2020. Report
> A new meta-analysis from The Lancet suggests that Eli Lilly's ($LLY) withdrawn sepsis drug Xigris may be more beneficial than previously thought. Report (reg. req.)
> An Australian drug distributor, Diageo, agreed to pay "a multimillion-dollar amount" to a patient born without arms or legs after her mother used thalidomide during pregnancy. Report
> Federal prosecutors charged four dozen people in a $108 million Medicaid fraud scheme, saying the ring diverted drugs for Medicaid recipients to black-market sales. Report
> The state of Georgia delayed an execution to next week to enable a switch from a lethal injection cocktail of three drugs to just one, pentobarbital. Report
> The Obama Administration's mandate that insurers provide contraceptives free of charge survived a federal-court challenge by 7 states. Report
> The European Commission earmarked 4.3 million euros to help 700 laid-off AstraZeneca ($AZN) workers in Sweden transition to new jobs. Report
Biotech News
@FierceBiotech: Boehringer backs study of mobile diabetes care. Story | Follow @FierceBiotech
@JohnCFierce: Buzz: Big investors likely to back next wave of biotech buyouts. Report | Follow @JohnCFierce
@RyanMFierce: I sense a micro tech bubble forming in genomic data interpretation, annotation software. I see a new company in this space every month or so. | Follow @RyanMFierce
> GSK boosts stake in Amicus as PhIII Fabry data looms. Article
> FDA hits green light on Vivus weight drug Qnexa. News
> Amag preps sNDA after Feraheme clears PhIII hurdles. Item
@FierceMedDev: Teleflex says it's buying catheter firm Hotspur for $15M and selling off its ortho unit for $45M. Item | Follow @FierceMedDev
@MarkHFierce: St. Jude's Medical's Q2 earnings disappoint. Story | Follow @MarkHFierce
@DamianFierce: Steris is buying U.S. Endoscopy for $270M in cash. More | Follow @DamianFierce
> Mindray seals $35M deal for Dragonbio's orthopedics implant line. More
> Abbott's Dx investment pays off with Q2 growth. Story
Drug Delivery News
> Ex-Sanofi exec joins Kala as President and CEO. Story
> Tekmira's technology delivers Alnylam Phase I RNAi results. Article
> Tea leaves could deliver prostate cancer treatment. More
> Microparticles deliver vaccines to the gut. Item
> NuPathe stock climbs on migraine patch resubmission. News
Biomarkers News
> The ethics of Alzheimer's risk testing. Report
> Genetic biomarkers tag antipsychotic weight gain. Article
> U.S. researchers gain $6.5 M grant to smoke out COPD markers. News
> Markers map slide into Alzheimer's. More
> Biomarkers could make multiple sclerosis diagnosis easier. Story
> DeCode, Genentech find gene mutation marks protection against Alzheimer's. Article
> Gold stars in ultrasensitive biomarker test. Item
And Finally... The latest U.S. export: a sedentary lifestyle, and the expanding waistline that comes with it. Report